跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES
Approved
STANDARD
ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES
Bayer Bulgaria Eood
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 29, 2021
Approval ID
40626e6da10400cd
Company
Bayer Bulgaria Eood
Type
Standard
Approval Details
Approval Id
40626e6da10400cd
Drug Cima Aemps Name
ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES
Register Number
20000836IP
Holder Company Name
Bayer Bulgaria Eood
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2021-04-29
Dosage Form
COMPRIMIDO EFERVESCENTE
Dose
400 mg/240 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Bayer Bulgaria Eood
Active Ingredients
ACETILSALICILICO ACIDO
400 mg
ASCORBICO ACIDO
240 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 29, 2021
Approval ID
40626e6da10400cd
Type
Standard
Back to CIMA-AEMPS Approvals
